We are committed to helping employees and teams at ETH Zurich to fully exploit their potential and hence provide high performance within our organization.
Revidia Therapeutics Inc., a cardiac regenerative medicine company developing first-in-class small molecule drug therapies for heart injury, has announced that it has expanded its leadership team in ...